MINT-AD
Multimodal Interpretable Transformer for Alzheimer's Disease
Empowering Clinical Excellence
MINT-AD leverages decades of international research in genomics, clinical practice, and cognitive science into a clinical decision support tool.
Data Integration & Purpose
A comprehensive data integration allows MINT-AD to identify subtle changes and detect early patterns of cognitive decline.
Cognitive Tests
Cognitive Tests
Neuropsychological evaluations, memory, & language attention.
Omics Data
Omics Data
Genetics, specific biomarkers, and epigenetics.
Brain Images
Brain Images
Magnetic Resonance Imaging (MRI), Computed Tomography scans, & PET
Clinical History
Clinical History
Family history, over 390 medical variables
Demographic
Demographic
Age, gender, living conditions, and other socioeconomic factors.
Reduces diagnostic delays in underserved areas where there’s a lack of resources and equipment for diagnosis.
Reduces diagnosis times in disadvantaged communities and improves the impact of public policies, in alignment with clinical research standards found on ClinicalTrials.gov
Understanding combinations of socioeconomic and lifestyle factors.
Discover aha™
High-quality prediction starts with high-quality data. aha™ automatically harmonizes clinical, imaging, sociodemographic, and molecular datasets for Alzheimer’s disease, transforming heterogeneous cohorts into a single, trustworthy dataset ready for advanced analytics and AI models.
